3De Hert S,Foubert L,Poelaert J,et al.Beta-adrenergic blocking drugs in the perioperative Period[J].Acta Anaesthesiol Belg,2003,54(2):127.
二级参考文献32
1Strong K, Bonita R: The SuRF Report 1. Surveillance of risk factors related to non-communicable diseases: current status of global data[R]. Geneva, Switzerland: Non communicable Diseases and Mental Health. World Health Organization, 2003.
2The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. U.S. Department of Health and Human Services[R]. National Institutes of Health and National Heart, Lung and Blood Institute. 2003.
3The sixth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure[J]. Arch Intern Med,1997, 157∶2413-2446.
4Goldman L, Caldera DL. Risks of general anesthesia and elective operation in the hypertensive patient[J]. Anesthesiology,1979,50∶285-292.
5Estafanous FG, Tarazi RC, Viljonen JF,et al. Systemic hypertension following myocardial revascularization[J]. Am Heart J,1973,85∶732-738.
6Gottdiener JS, Brown J, Zoltick J, et al. Left ventricular hypertrophy in men with normal blood pressure: relation to exaggerated blood pressure response to exercise[J]. Ann Intern Med,1990,112∶161-166.
7The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the joint national Committee on detection, evaluation, and treatment of high blood pressure[J]. Arch Intern Med, 1993,153∶154-183.
8Prys-Roberts C, Meloche R, Foex P, et al. Studies of anaesthesia in relation to hypertension. I. Cardiovascular responses of treated and untreated patients[J].Br J Anaesth, 1971, 43(2)∶122-137.
9Black HR. The paradigm has shifted, to systolic blood pressure[J]. Hypertension, 1999, 34∶386-387.
10Smulyan H, Safar ME. The diastolic blood pressure in systolic hypertension[J]. Ann Intern Med, 2000, 132∶233-237.
6Martfnez - Caselles A, Pons - Minano JA, Vargas - Acosta 6, et al. Hepatoportal sclerosis clinical different evolutionary stages:presenta- tion of 3 cases and literature review. Rev Esp Enferm Dig( Madrid),2012,104(2) :94 -97.
7Young S, Lie SA, Hallan G, et al. Low infection rates after 34,361 intramedullary nail operations in 55 low - and middle - income countries. Acta Orthopaedica,2011,82 (6) :737 - 743.
8Pak J. Autologous Adipose Tissue - Derived Stem Ceils Induce Per- sistent Bone - Like Tissue in Osteonecrotic Femoral Heads. Pain Physician,2012, 1:5 (3) :252 - 261.
9Ullmark G, Sundgren K, Milbrink J, et al. Metabolic development of necrotic bone in the femoral head following resurfacing arthroplas- ty. Acta Orthopaedica,2012,83 (01) :22 - 25.
10Tetik C, Basar H, Bezer M, et al. Comparison of early results of vascularized and non - vascularized fibular grafting in the treatment of osteonecrosis of the femoral head. Acta Orthop Traumatol Turc 2011,45(5) :326 -334.
